Short-term Observation of Direct Oral Anticoagulant Use in an Atrial Fibrillation Patient with High Bleeding Risk and Kidney Transplant: a Case Report

Overview

Journal J Geriatr Cardiol

Specialty Geriatrics

Date 2021 Sep 16

PMID 34527035

Authors

Wei Xiang

Ling-Yun Kong

Jing Bai

Jun-Jie Xie

Fang Liu

Affiliations

Soon will be listed here.

References

Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D . Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011; 11(10):2093-109. DOI: 10.1111/j.1600-6143.2011.03686.x. View

Leon J, Sabbah L, Aubert O, Anglicheau D, Delavenne X, Zuber J . Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot Experience. Transplantation. 2020; 104(12):2625-2631. DOI: 10.1097/TP.0000000000003168. View

Eriksson B, Quinlan D, Weitz J . Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development. Clin Pharmacokinet. 2008; 48(1):1-22. DOI: 10.2165/0003088-200948010-00001. View

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016; 18(11):1609-1678. DOI: 10.1093/europace/euw295. View

Amundsen R, Asberg A, Ohm I, Christensen H . Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. Drug Metab Dispos. 2011; 40(4):655-61. DOI: 10.1124/dmd.111.043018. View

Malyszko J, Lopatowska P, Mlodawska E, Musialowska D, Malyszko J, Tomaszuk-Kazberuk A . Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?. Nephrol Dial Transplant. 2017; 33(8):1304-1309. DOI: 10.1093/ndt/gfx265. View

January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J . 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the.... Circulation. 2019; 140(2):e125-e151. DOI: 10.1161/CIR.0000000000000665. View

Steffel J, Verhamme P, Potpara T, Albaladejo P, Antz M, Desteghe L . The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018; 39(16):1330-1393. DOI: 10.1093/eurheartj/ehy136. View

Bukhari M, Al-Theaby A, Tawhari M, Al-Shaggag A, Pyrke R, Gangji A . Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation. World J Transplant. 2019; 9(6):134-144. PMC: 6851500. DOI: 10.5500/wjt.v9.i6.134. View

10.

Camporese G, Bernardi D, Bernardi E, Avruscio G, Marchini F, Bonfante L . Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation. Vascul Pharmacol. 2020; 130:106682. DOI: 10.1016/j.vph.2020.106682. View

11.

Basic-Jukic N, Furic-Cunko V, Juric I . Novel Oral Anticoagulants in Renal Transplant Recipients: A Retrospective Cohort Study. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2020; 41(2):49-55. DOI: 10.2478/prilozi-2020-0032. View

12.

Thongprayoon C, Chokesuwattanaskul R, Bathini T, Khoury N, Sharma K, Ungprasert P . Epidemiology and Prognostic Importance of Atrial Fibrillation in Kidney Transplant Recipients: A Meta-Analysis. J Clin Med. 2018; 7(10). PMC: 6210475. DOI: 10.3390/jcm7100370. View

13.

Purnell T, Auguste P, Crews D, Lamprea-Montealegre J, Olufade T, Greer R . Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis. 2013; 62(5):953-73. PMC: 3809150. DOI: 10.1053/j.ajkd.2013.03.022. View

14.

Lemahieu W, Maes B, Verbeke K, Vanrenterghem Y . CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. Am J Transplant. 2004; 4(9):1514-22. DOI: 10.1111/j.1600-6143.2004.00539.x. View

15.

Chan N, Sobieraj-Teague M, Eikelboom J . Direct oral anticoagulants: evidence and unresolved issues. Lancet. 2020; 396(10264):1767-1776. DOI: 10.1016/S0140-6736(20)32439-9. View